1. Home
  2. UXIN vs VIR Comparison

UXIN vs VIR Comparison

Compare UXIN & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UXIN
  • VIR
  • Stock Information
  • Founded
  • UXIN 2011
  • VIR 2016
  • Country
  • UXIN China
  • VIR United States
  • Employees
  • UXIN N/A
  • VIR N/A
  • Industry
  • UXIN Business Services
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • UXIN Consumer Discretionary
  • VIR Health Care
  • Exchange
  • UXIN Nasdaq
  • VIR Nasdaq
  • Market Cap
  • UXIN 637.1M
  • VIR 724.1M
  • IPO Year
  • UXIN 2018
  • VIR 2019
  • Fundamental
  • Price
  • UXIN $4.32
  • VIR $5.50
  • Analyst Decision
  • UXIN
  • VIR Strong Buy
  • Analyst Count
  • UXIN 0
  • VIR 7
  • Target Price
  • UXIN N/A
  • VIR $33.57
  • AVG Volume (30 Days)
  • UXIN 24.2K
  • VIR 1.4M
  • Earning Date
  • UXIN 04-28-2025
  • VIR 05-01-2025
  • Dividend Yield
  • UXIN N/A
  • VIR N/A
  • EPS Growth
  • UXIN N/A
  • VIR N/A
  • EPS
  • UXIN N/A
  • VIR N/A
  • Revenue
  • UXIN $232,096,942.00
  • VIR $74,205,000.00
  • Revenue This Year
  • UXIN $26.86
  • VIR N/A
  • Revenue Next Year
  • UXIN N/A
  • VIR $17.69
  • P/E Ratio
  • UXIN N/A
  • VIR N/A
  • Revenue Growth
  • UXIN 11.56
  • VIR N/A
  • 52 Week Low
  • UXIN $1.41
  • VIR $4.95
  • 52 Week High
  • UXIN $7.84
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • UXIN 57.54
  • VIR 35.61
  • Support Level
  • UXIN $3.31
  • VIR $5.32
  • Resistance Level
  • UXIN $4.17
  • VIR $5.73
  • Average True Range (ATR)
  • UXIN 0.41
  • VIR 0.45
  • MACD
  • UXIN 0.06
  • VIR 0.05
  • Stochastic Oscillator
  • UXIN 86.44
  • VIR 32.35

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: